Takahashi, N.; Nakashima, R.; Nasu, A.; Hayashi, M.; Fujikawa, H.; Kawakami, T.; Eto, Y.; Kishimoto, T.; Fukuyama, A.; Ogasawara, C.;
et al. T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model. Antioxidants 2024, 13, 30.
https://doi.org/10.3390/antiox13010030
AMA Style
Takahashi N, Nakashima R, Nasu A, Hayashi M, Fujikawa H, Kawakami T, Eto Y, Kishimoto T, Fukuyama A, Ogasawara C,
et al. T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model. Antioxidants. 2024; 13(1):30.
https://doi.org/10.3390/antiox13010030
Chicago/Turabian Style
Takahashi, Noriki, Ryunosuke Nakashima, Aoi Nasu, Megumi Hayashi, Haruka Fujikawa, Taisei Kawakami, Yuka Eto, Tomoki Kishimoto, Ayami Fukuyama, Choyo Ogasawara,
and et al. 2024. "T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model" Antioxidants 13, no. 1: 30.
https://doi.org/10.3390/antiox13010030
APA Style
Takahashi, N., Nakashima, R., Nasu, A., Hayashi, M., Fujikawa, H., Kawakami, T., Eto, Y., Kishimoto, T., Fukuyama, A., Ogasawara, C., Kawano, K., Fujiwara, Y., Suico, M. A., Kai, H., & Shuto, T.
(2024). T3 Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model. Antioxidants, 13(1), 30.
https://doi.org/10.3390/antiox13010030
